Drug Discovery Europe 2026 brings every part of modern discovery into one unified programme. Target identification, medicinal and computational chemistry, organoids, advanced in‑vitro models, AI‑driven screening, functional genomics, multi‑omics discovery, PROTACs, molecular glues, ADCs, digital‑lab infrastructure, robotics, FAIR data, neuro‑biomarkers, BBB delivery science and neuroinflammation all sit together as one continuum—reflecting how discovery, automation and neuroscience now operate as an integrated pipeline.

The event attracts senior‑level R&D leaders, showcases high‑value case studies, and delivers the intelligence needed to benchmark methods, validate strategy and stay aligned with the direction of industry‑leading discovery teams. Delegates gain access to cutting‑edge science, cross‑functional insight and the connections that shape real R&D decision‑making.

To find out more or register, click here.